Novel and Controversial Therapies in COVID-19

  • Singh R
  • Shaik L
  • Mehra I
  • et al.
14Citations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19.

Cite

CITATION STYLE

APA

Singh, R., Shaik, L., Mehra, I., Kashyap, R., & Surani, S. (2021). Novel and Controversial Therapies in COVID-19. The Open Respiratory Medicine Journal, 14(1), 79–86. https://doi.org/10.2174/1874306402014010079

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free